Last checked at 
25 Oct 2016 12:57
INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 September 2016
Net Assets | £229m |
Net Assets per share | 611p |
Share price | 548p |
Total value of unquoted investments | £23m |
Total number of portfolio companies | 85 |
Top Ten Holdings
Company Name | % NAV |
Biogen | 7.5 |
Celgene | 6.6 |
Regeneron | 6.1 |
Genmab | 4.4 |
Incyte | 4.3 |
Gilead | 3.9 |
Illumina | 3.6 |
Amgen | 3.6 |
Alexion | 3.6 |
Biomarin | 3.1 |
----------- | |
Total | 46.7 |
Geographical Allocation | % NAV |
US & Canada | 78 |
Europe & UK | 22 |
----------- | |
Total | 100 |
Quoted/Unquoted Allocation | % NAV |
Quoted | 90 |
Unquoted | 10 |
----------- | |
Total | 100 |
NAV % Market Cap | % NAV |
Large Cap >USD10BN | 52 |
Mid Cap =USD1-10BN | 25 |
Small Cap | 23 |
----------- | |
Total | 100 |
NAV % by Therapeutic Areas | % NAV |
Oncology | 35 |
Orphan | 17 |
CNS | 11 |
Inflammation | 10 |
Ophthalmology | 8 |
Medtech | 2 |
Other | 17 |
----------- | |
Total | 100 |
BNP Paribas Secretarial Services Limited
Company Secretary
25 OCTOBER 2016